|
ERN-LUNG welcomes new leads and deputy leads for the following Core Networks:
CLAD: Jens Gottlieb from Medizinische Hochschule Hannover, Germany, deputy: Federica Meloni, Pavia University, Italy
BRONCHIECTASIS: Eva Polverino, deputy: Sandra Rovira, both from University Hospital Vall d´Hebron, Spain,
as well as the newly established Core Network Sarcoidosis in March 2023, lead by Francesco Bonella, Universitätsklinikum Essen, Germany and his deputy leads Paolo Spagnolo, University of Padova, Italy and Jacobo Sellares, Hospital Clinic, Barcelona, Spain.
Furthermore, the ORLD Core Network, lead by Helge Hebestreit (Würzburg, Germany), welcomes his new deputy lead, Horst Olschewski, University Hospital Graz, Austria, as well as three new group members:
Ilaria Campa, Pavia University Hospital, Italy, Julien Guiot, Universite de Liege, Belgium and Peter Merkus from the Radboud University, The Netherlands.
New FC lead: Research & Clinical Trials Networks
ERN-LUNG is delighted to announce the appointment of Professor Kim Gjerum Nielsen as the new Functional Committee lead for "Research and Clinical Trials Networks."
Professor Kim G. Nielsen brings a wealth of expertise as a professor in pediatrics and Chief Consultant overseeing the Paediatric Pulmonary Service at Copenhagen University Hospital, Rigshospitalet, Denmark. His specialization includes chronic lung diseases such as CF, PCD, and ILD in children, but has also considerable experience in adult PCD. Notably, Professor Nielsen has played a pivotal role in the establishment of the PCD Clinical Trials Network (PCD CTN) in collaboration with the PCD Core Network of ERN-LUNG, where he serves as the director and coordinator.
We believe that Professor Nielsen possesses the essential qualities to guide ERN-LUNG's Functional Committee and contribute to the advancement of Research and Clinical Trials Networks. His proven success in establishing the PCD CTN reflects his dedication to fostering collaborative initiatives within ERN-LUNG. We are confident that he will effectively share his insights and ideas with other Core Networks, further promoting the concept of Clinical Trials Networks.
Professor Nielsen's role extends beyond leadership; he is committed to supporting all members of ERN-LUNG in optimizing the network's structure for trans-European research projects. We encourage everyone within ERN-LUNG to seek his assistance in establishing core-specific clinical trial networks. With Professor Kim Gjerum Nielsen taking the lead, we look forward to achieving new milestones in research collaboration and advancing our collective mission. |